BRPI0515749A - detecção e quantificação de ciclodextrinas - Google Patents

detecção e quantificação de ciclodextrinas

Info

Publication number
BRPI0515749A
BRPI0515749A BRPI0515749-8A BRPI0515749A BRPI0515749A BR PI0515749 A BRPI0515749 A BR PI0515749A BR PI0515749 A BRPI0515749 A BR PI0515749A BR PI0515749 A BRPI0515749 A BR PI0515749A
Authority
BR
Brazil
Prior art keywords
cyclodextrins
detection
quantification
relates
quantitation
Prior art date
Application number
BRPI0515749-8A
Other languages
English (en)
Inventor
Zoran Sosic
Rulin Qian
James Ahern
Rohin Mhatre
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of BRPI0515749A publication Critical patent/BRPI0515749A/pt
Publication of BRPI0515749B1 publication Critical patent/BRPI0515749B1/pt
Publication of BRPI0515749B8 publication Critical patent/BRPI0515749B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"DETECçãO E QUANTIFICAçãO DE CICLODEXTRINAS". A presente invenção refere-se à detecção e quantificação de ciclodextrinas e derivados de ciclodextrinas em soluções compreendendo uma proteína. A invenção ainda se refere a métodos de avaliação de preparações farmacêuticas quanto à presença de ciclodextrinas residuais.
BRPI0515749A 2004-12-06 2005-12-05 métodos para testar quanto à presença de ciclodextrina ou derivado de ciclodextrina em uma solução compreendendo proteína, para determinação da quantidade de ciclodextrina ou derivado de ciclodextrina que possa estar presente em uma solução compreendendo proteína e de avaliação de preparação farmacêutica BRPI0515749B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63316204P 2004-12-06 2004-12-06
PCT/US2005/043869 WO2006062881A2 (en) 2004-12-06 2005-12-05 Detection and quantitation of cyclodextrins

Publications (3)

Publication Number Publication Date
BRPI0515749A true BRPI0515749A (pt) 2008-08-05
BRPI0515749B1 BRPI0515749B1 (pt) 2019-01-02
BRPI0515749B8 BRPI0515749B8 (pt) 2021-07-27

Family

ID=36578444

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515749A BRPI0515749B8 (pt) 2004-12-06 2005-12-05 métodos para testar quanto à presença de ciclodextrina ou derivado de ciclodextrina em uma solução compreendendo proteína, para determinação da quantidade de ciclodextrina ou derivado de ciclodextrina que possa estar presente em uma solução compreendendo proteína e de avaliação de preparação farmacêutica

Country Status (17)

Country Link
US (2) US8232064B2 (pt)
EP (1) EP1828772B1 (pt)
JP (1) JP5065043B2 (pt)
KR (1) KR101257118B1 (pt)
CN (2) CN101073010A (pt)
AT (1) ATE466282T1 (pt)
AU (1) AU2005314235B2 (pt)
BR (1) BRPI0515749B8 (pt)
CA (1) CA2590728C (pt)
DE (1) DE602005020977D1 (pt)
DK (1) DK1828772T3 (pt)
IL (1) IL183547A (pt)
MX (1) MX2007006432A (pt)
NO (1) NO342750B1 (pt)
NZ (1) NZ556106A (pt)
WO (1) WO2006062881A2 (pt)
ZA (1) ZA200704269B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062881A2 (en) * 2004-12-06 2006-06-15 Biogen Idec Ma Inc. Detection and quantitation of cyclodextrins
CN101685083B (zh) * 2009-04-30 2011-11-23 贾正平 用于测定羟丙基-β-环糊精的超快速液相色谱-串联质谱法
CN103500331B (zh) * 2013-08-30 2017-11-10 北京智谷睿拓技术服务有限公司 提醒方法及装置
CN103776806B (zh) * 2014-01-06 2016-01-06 浙江农林大学 包合物包合率测定仪的测定方法
CN105237658B (zh) * 2015-09-24 2018-05-22 荆楚理工学院 一种荧光修饰环糊精及其制备方法和应用
CA3159894A1 (en) * 2019-12-16 2021-06-24 Seagen Inc. High performance liquid chromatography quantification of excipients
CN114324659A (zh) * 2021-12-29 2022-04-12 江苏海悦康医药科技有限公司 一种伽马环糊精中有机杂质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843397B1 (fr) * 2002-08-06 2004-10-15 Chelator Nouveaux derives de cyclodextrines, leur procede de preparation et leurs applications
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
WO2006062881A2 (en) * 2004-12-06 2006-06-15 Biogen Idec Ma Inc. Detection and quantitation of cyclodextrins
CN100572500C (zh) * 2007-11-09 2009-12-23 南开大学 环糊精修饰的CdTe量子点的水相制备方法

Also Published As

Publication number Publication date
KR101257118B1 (ko) 2013-04-22
AU2005314235A1 (en) 2006-06-15
EP1828772B1 (en) 2010-04-28
ATE466282T1 (de) 2010-05-15
US8232064B2 (en) 2012-07-31
US20090227039A1 (en) 2009-09-10
NO20073454L (no) 2007-07-06
WO2006062881A3 (en) 2006-08-31
BRPI0515749B1 (pt) 2019-01-02
DK1828772T3 (da) 2010-08-23
CA2590728C (en) 2016-10-11
MX2007006432A (es) 2007-07-19
EP1828772A4 (en) 2008-03-26
US20130005043A1 (en) 2013-01-03
ZA200704269B (en) 2009-03-25
JP2008523362A (ja) 2008-07-03
NO342750B1 (no) 2018-08-06
KR20070090232A (ko) 2007-09-05
IL183547A0 (en) 2007-09-20
CA2590728A1 (en) 2006-06-15
EP1828772A2 (en) 2007-09-05
CN103217500A (zh) 2013-07-24
US8465935B2 (en) 2013-06-18
IL183547A (en) 2010-12-30
AU2005314235B2 (en) 2012-11-08
BRPI0515749B8 (pt) 2021-07-27
WO2006062881A2 (en) 2006-06-15
CN103217500B (zh) 2016-08-03
DE602005020977D1 (de) 2010-06-10
CN101073010A (zh) 2007-11-14
NZ556106A (en) 2009-07-31
JP5065043B2 (ja) 2012-10-31

Similar Documents

Publication Publication Date Title
NO20073454L (no) Påvisning og kvantifisering av cyklodekstriner
EP1929073A4 (en) PROTEIN MEDICAMENT AND ITS USE
FI20051318L (fi) Selluloosapitoisen materiaalin käsittely ja siihen käytettäviä entsyymejä
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
EP2064345A4 (en) PSORASE-ASSOCIATED GENETIC POLYMORPHIA, PROOF METHOD AND ITS USE
WO2005057166A3 (en) Detection of conformationally altered proteins and prions
MA28478B1 (fr) Derive du benzimidazole et ses utilisations
FI20055232L (fi) Järjestelmä ja menetelmä maasulkuvian sijainnin määrittämiseksi
EP1874351A4 (en) ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS, AND APPLICATIONS
NO20042409L (no) System og metode for detektering av tilstedevaerelse.
EP2007899A4 (en) ANGIOPOIETIN-LIKE PROTEIN 4-FACED ANTIBODIES AND THEIR USE
FI20050706L (fi) Menetelmä ja tuote vianilmaisuun
DE602006021683D1 (de) Trennsignalverarbeitungsvorrichtung und Softwareversionsaktualisierungsverfahren dafür
NO20052403D0 (no) System and method for intrusion detection.
EP1848672A4 (en) LIBRARIES AND METHOD FOR ISOLATING ANTIBODIES
AU2003228254A1 (en) Detection of biospecific interactions using amplified differential time domain spectroscopy signal
NL1025574A1 (nl) Werkwijze en systeem voor verbeteren van detectie van transiente ruis.
DK1515740T3 (da) Vandigt præparat indeholdende oligopeptider og foretheret cyclodextrin
WO2006088823A3 (en) Method for detecting misfolded proteins and prions
EP1893218A4 (en) UNLOCKED BENZODIAZEPINE COMPOSITIONS AND METHOD
EP1929044A4 (en) METHOD AND SAMPLE COMBINATIONS FOR MELANOMA DETECTION
EP1928250A4 (en) BEERING PREPARATIONS AND EXTRACTS
EP1778206A4 (en) SMALL MOLECULE INHIBITORS FROM MEMBERS OF THE ANTIOPTOTIC BCL-2 FAMILY AND USES THEREOF
GB2442544B (en) Protein detection and quantitation using hydroxyquinolone dyes
DE602006020231D1 (de) Detektionsvorrichtung und -verfahren

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2153 DE 10/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BIOGEN MA INC. (US)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B25I Requirement for requested change of headquarter

Owner name: BIOGEN MA INC. (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: BIOGEN MA INC. (US)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/01/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/12/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO